BamSEC and AlphaSense Join Forces
Learn More

Pasithea Therapeutics Corp. – Articles of Incorporation

NASDAQ: KTTA    
Share price (6/2/26): $0.65    
Market cap (6/2/26): $21.6 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp
12/34/56
EX-3.4
from 8-K 2 pages Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Termination of Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp
12/34/56
EX-3.2
from 8-K 14 pages Second Amended and Restated Bylaws of Pasithea Therapeutics Corp. a Delaware Corporation
12/34/56
EX-3.1
from 8-K 6 pages Second Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp
12/34/56
EX-3.2
from 10-K 20 pages Amended and Restated Bylaws of Pasithea Therapeutics Corp. a Delaware Corporation
12/34/56
EX-3
from SC 13D/A ~1 page Investor Group Comments on Pasithea Therapeutics’ Seemingly Defensive and Dilutive Related-Party Acquisition of Alpha-5 Intends to Withhold on All of Pasithea’s Sitting Directors at the Upcoming Annual Meeting of Stockholders Plans to Call a Special Meeting to Remove and Replace Pasithea’s Board of Directors, Which Is Accountable for Misalignment, Poor Governance and Rapid Value Destruction
12/34/56
EX-3.2
from S-1 28 pages I Bylaws of Pasithea Therapeutics Corp
12/34/56
EX-3.1
from S-1 9 pages Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp
12/34/56